Business

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics’ unique fibroblast cell-based approach for the potential treatment of chronic d

articleFibrobiologics, Inc.April 11, 20251/company/fibrobiologics-inc-common-stock/news/fibrobiologics-present-cell-gene-meeting-123000125
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

About this update from Fibrobiologics, Inc.

[{"type":"image","alt":"Fibrobiologics, Inc.","displaySize":"","headline":null,"caption":"Fibrobiologics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":77,"url":"https://media.zenfs.com/en/globenewswire.com/ea452943381e269d15ec4a2f87674425"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xw_QEbMhw7ViThavcOHCOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ea452943381e269d15ec4a2f87674425","width":300,"height":77}},"lazy":false},{"type":"text","content":"HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Hamid Khoja, Ph.D., Chief Scientific Officer of FibroBiologics, will present on FibroBiologics’ unique fibroblast cell-based approach for the potential treatment of chronic diseases at The Cell & Gene Meeting On The Mediterranean (Med) in Rome, Italy, from April 15-17, 2025. The Cell & Gene Meeting on the Med is the leading conference bringing together the Advanced Therapy Medicinal Products community from Europe and beyond.","length":767,"tagName":"p"},{"type":"text","content":"Details of the conference and presentations are as follows:","length":59,"tagName":"p"},{"type":"text","content":"The Cell & Gene Meeting On The Med ","length":38,"tagName":"p"},{"type":"text","content":"Presentation Title: Restoring Immune system homeostasis using a fibroblast cell-based therapeutic targeting three chronic inflammation-mediated diseases","length":157,"tagName":"p"},{"type":"text","content":"Presenter: Hamid Khoja, Ph.D., Chief Scientific Officer, FibroBiologics","length":76,"tagName":"p"},{"type":"text","content":"Location: Salone dei Cavalieri, Section 2","length":46,"tagName":"p"},{"type":"text","content":"Date and Time: Wednesday, April 16 at 9:00 AM CEST","length":55,"tagName":"p"},{"type":"text","content":"For more information, please visit FibroBiologics' website or email FibroBiologics at: [email protected].","length":115,"tagName":"p"},{"type":"text","content":"About FibroBiologics","length":20,"tagName":"p"},{"type":"text","content":"Based in...

More updates from Fibrobiologics, Inc.

FibroBiologics, Inc.chronic diseasesChief Scientific Officerbiotechnology companyFibroBiologicsfibroblast cellsGene Meeting